Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

키워드

참고문헌 (15)

1. Kim BK, "Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B : what else to keep in mind : Editorial on"Hepatocellular carcinoma prediction model performance decreases with longterm antiviral therapy in chronic hepatitis B patients"", Clin Mol Hepatol, 30, pp.656~658 (2024)
2. Wu X, "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients", Clin Mol Hepatol, 29, pp.747~762 (2023)
3. Wen X, "Longterm antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB", J Med Virol, 96, pp.e29606~ (2024)
4. Kramvis A, "A roadmap for serum biomarkers for hepatitis B virus : current status and future outlook", Nat Rev Gastroenterol Hepatol, 19, pp.727~745 (2022)
5. Kim HY, "An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B", J Hepatol, 76, pp.311~318 (2022)
6. Zhao L, "Incorporating longitudinal biomarkers for dynamic risk prediction in the era of big data : A pseudo-observation approach", Stat Med, 39, pp.3685~3699 (2020)
7. Zhu Q, "Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy", J Cancer Res Clin Oncol, 149, pp.12691~12701 (2023)
8. Nam H, "Prediction of hepatocellular carcinoma by on-therapy response of noninvasive fibrosis markers in chronic hepatitis B", Am J Gastroenterol, 116, pp.1657~1666 (2021)
9. Fan R, "Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures", J Hepatol, 79, pp.933~944 (2023)
10. De Vincentis A, "A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores", Clin Gastroenterol Hepatol, 20, pp.658~673 (2022)
11. Gellert-Kristensen H, "Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population", Hepatology, 72, pp.845~856 (2020)
12. Xing X, "Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma", Nat Commun, 14, pp.8392~ (2023)
13. Li ZY, "Prediagnostic plasma metabolite concentrations and liver cancer risk : a population-based study of Chinese men", EBioMedicine, 100, pp.104990~ (2024)
14. Yoo J, "Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection", Clin Mol Hepatol, 29, pp.1029~1042 (2023)
15. Yip TC, "Diabetes mellitus impacts on the performance of hepatocellular carcinoma risk scores in chronic hepatitis B patients", Clin Gastroenterol Hepatol, 21, pp.2864~2875 (2023)

관련 논문AI추천